A detailed history of Emerald Mutual Fund Advisers Trust transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Emerald Mutual Fund Advisers Trust holds 429,302 shares of RARE stock, worth $18.8 Million. This represents 1.35% of its overall portfolio holdings.

Number of Shares
429,302
Previous 390,524 9.93%
Holding current value
$18.8 Million
Previous $16.1 Million 48.58%
% of portfolio
1.35%
Previous 0.91%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$40.21 - $59.36 $1.56 Million - $2.3 Million
38,778 Added 9.93%
429,302 $23.8 Million
Q2 2024

Aug 06, 2024

BUY
$37.42 - $51.61 $193,985 - $267,546
5,184 Added 1.35%
390,524 $16.1 Million
Q4 2023

Feb 05, 2024

SELL
$31.73 - $49.19 $62,920 - $97,543
-1,983 Reduced 0.51%
385,340 $18.4 Million
Q3 2023

Oct 26, 2023

SELL
$34.92 - $46.66 $1.84 Million - $2.46 Million
-52,818 Reduced 12.0%
387,323 $13.8 Million
Q2 2023

Aug 10, 2023

BUY
$37.35 - $52.15 $1.93 Million - $2.69 Million
51,613 Added 13.28%
440,141 $20.3 Million
Q1 2023

May 04, 2023

BUY
$36.99 - $48.71 $5.02 Million - $6.61 Million
135,676 Added 53.66%
388,528 $15.6 Million
Q4 2022

Feb 03, 2023

BUY
$33.72 - $46.33 $493,930 - $678,641
14,648 Added 6.15%
252,852 $11.7 Million
Q3 2022

Oct 25, 2022

BUY
$39.96 - $66.14 $2.87 Million - $4.75 Million
71,866 Added 43.2%
238,204 $9.86 Million
Q2 2022

Jul 29, 2022

SELL
$45.8 - $85.4 $726,662 - $1.35 Million
-15,866 Reduced 8.71%
166,338 $9.92 Million
Q1 2022

Apr 29, 2022

SELL
$62.2 - $84.4 $3.64 Million - $4.94 Million
-58,565 Reduced 24.32%
182,204 $13.2 Million
Q4 2021

Feb 02, 2022

BUY
$73.71 - $87.86 $10.2 Million - $12.2 Million
138,892 Added 136.33%
240,769 $20.2 Million
Q3 2021

Oct 28, 2021

SELL
$77.92 - $102.4 $9.52 Million - $12.5 Million
-122,205 Reduced 54.54%
101,877 $9.19 Million
Q2 2021

Jul 29, 2021

SELL
$92.19 - $115.71 $1.38 Million - $1.73 Million
-14,941 Reduced 6.25%
224,082 $21.4 Million
Q1 2021

Apr 29, 2021

BUY
$106.9 - $167.73 $2.21 Million - $3.46 Million
20,633 Added 9.45%
239,023 $27.2 Million
Q4 2020

Jan 29, 2021

BUY
$84.4 - $177.39 $18.4 Million - $38.7 Million
218,390 New
218,390 $30.2 Million

Others Institutions Holding RARE

About Ultragenyx Pharmaceutical Inc.


  • Ticker RARE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,036,896
  • Market Cap $3.06B
  • Description
  • Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...
More about RARE
Track This Portfolio

Track Emerald Mutual Fund Advisers Trust Portfolio

Follow Emerald Mutual Fund Advisers Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Emerald Mutual Fund Advisers Trust, based on Form 13F filings with the SEC.

News

Stay updated on Emerald Mutual Fund Advisers Trust with notifications on news.